Full Press Release Details
Immuron Limited (ASX: IMC)
The securities of Immuron
Limited ( IMC') will be placed in trading halt at the request of IMC, pending it releasing an announcement. Unless ASX decides
otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 7 March 2024
or when the announcement is released to the market.
| 5 March 2024 | Market Announcement 1/1 |
| ASX Limited | ASX Customer Service Centre 131 279 | asx.com.au |
Listings Compliance (Melbourne)
ASX Compliance Pty Ltd
Level 50, South Tower, Rialto
525 Collins St Melbourne VIC 3000
Request for Trading Halt
In accordance with ASX
Listing Rule 17.1, Immuron Limited (ASX: IMC; NASDAQ: IMRN) (the Company) requests an immediate trading halt in respect of its securities.
This trading halt is requested to allow Immuron to analyse and interpret data prior to making an announcement of Phase 2 IMM-124E clinical
trial top-line results.
The Company requests that
trading in its securities be halted until after the expected announcement is made or until the market opens on 7 March 2024, whichever
The Company is not aware of
any reason why this trading halt request should not be granted or of any other information necessary to inform the market about the trading
Please contact me if you
require any further information.
| Immuron Limited ABN 80 063 114 045 | Australia: +61 3 8892 4854 |
| www.immuron.com | USA and Canada: +1 (213) 817-5756 |